Press Releases - 2008
October 26, 2008High-Dose Influenza Vaccine Shows Increased Immune Response Among Adults 65 Years of Age and OlderJune 26, 2008
Federal Advisory Committee Votes to Include Newly Licensed Pentacel® Vaccine in Vaccines for Children ProgramJune 23, 2008
U.S. FDA Licenses Sanofi Pasteur’s New Pediatric Combination Vaccine, Pentacel®.June 16, 2008
Sanofi Pasteur to donate 60 million doses of H5N1 vaccine to WHO over 3 years for its influenza vaccine global stockpileMarch 13, 2008
U.S. FDA Licenses DAPTACEL® Vaccine for the Fifth Consecutive Dose in the Pediatric DTaP Immunization Series.February 26, 2008
Sanofi Pasteur Mounts Emergency Response to Yellow Fever Epidemic in Latin AmericaFebruary 20, 2008
Sanofi Pasteur US President expands role to lead Canadian and Latin American businessesFebruary 13, 2008
Sanofi Pasteur Files for European Approval of the First Seasonal Influenza Vaccine Delivered by Intradermal Microinjection
Access to categories:
